Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
BMC Genom Data ; 24(1): 26, 2023 05 02.
Article in English | MEDLINE | ID: mdl-37131148

ABSTRACT

HostSeq was launched in April 2020 as a national initiative to integrate whole genome sequencing data from 10,000 Canadians infected with SARS-CoV-2 with clinical information related to their disease experience. The mandate of HostSeq is to support the Canadian and international research communities in their efforts to understand the risk factors for disease and associated health outcomes and support the development of interventions such as vaccines and therapeutics. HostSeq is a collaboration among 13 independent epidemiological studies of SARS-CoV-2 across five provinces in Canada. Aggregated data collected by HostSeq are made available to the public through two data portals: a phenotype portal showing summaries of major variables and their distributions, and a variant search portal enabling queries in a genomic region. Individual-level data is available to the global research community for health research through a Data Access Agreement and Data Access Compliance Office approval. Here we provide an overview of the collective project design along with summary level information for HostSeq. We highlight several statistical considerations for researchers using the HostSeq platform regarding data aggregation, sampling mechanism, covariate adjustment, and X chromosome analysis. In addition to serving as a rich data source, the diversity of study designs, sample sizes, and research objectives among the participating studies provides unique opportunities for the research community.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , SARS-CoV-2/genetics , COVID-19/epidemiology , Canada/epidemiology , Genomics , Whole Genome Sequencing
2.
Mar Environ Res ; 101: 225-236, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25129449

ABSTRACT

Here we investigated mechanisms underlying the acclimation to light in the marine angiosperm Posidonia oceanica, along its bathymetric distribution (at -5 m and -25 m), combining molecular and photo-physiological approaches. Analyses were performed during two seasons, summer and autumn, in a meadow located in the Island of Ischia (Gulf of Naples, Italy), where a genetic distinction between plants growing above and below the summer thermocline was previously revealed. At molecular level, analyses carried out using cDNA-microarray and RT-qPCR, revealed the up-regulation of genes involved in photoacclimation (RuBisCO, ferredoxin, chlorophyll binding proteins), and photoprotection (antioxidant enzymes, xanthophyll-cycle related genes, tocopherol biosynthesis) in the upper stand of the meadow, indicating that shallow plants are under stressful light conditions. However, the lack of photo-damage, indicates the successful activation of defense mechanisms. This conclusion is also supported by several responses at physiological level as the lower antenna size, the higher number of reaction centers and the higher xanthophyll cycle pigment pool, which are common plant responses to high-light adaptation/acclimation. Deep plants, despite the lower available light, seem to be not light-limited, thanks to some shade-adaptation strategies (e.g. higher antenna size, lower Ek values). Furthermore, also at the molecular level there were no signs of stress response, indicating that, although the lower energy available, low-light environments are more favorable for P. oceanica growth. Globally, results of whole transcriptome analysis displayed two distinct gene expression signatures related to depth distribution, reflecting the different light-adaptation strategies adopted by P. oceanica along the depth gradient. This observation, also taking into account the genetic disjunction of clones along the bathymetry, might have important implications for micro-evolutionary processes happening at meadow scale. Further investigations in controlled conditions must be performed to respond to these questions.


Subject(s)
Alismatales/physiology , Light , Acclimatization , Alismatales/genetics , Alismatales/radiation effects , Gene Expression Profiling , Gene Expression Regulation, Plant , Genetic Variation , Oligonucleotide Array Sequence Analysis , Photosynthesis , Seasons , Temperature
3.
Clin Neurol Neurosurg ; 113(4): 277-80, 2011 May.
Article in English | MEDLINE | ID: mdl-21159421

ABSTRACT

OBJECTIVES: To report the results from the Brazilian database on multiple sclerosis (MS) and pregnancy. METHODS: Retrospective data from MS patients who became pregnant at any time of their disease were sent to a Brazilian database, using a specific file for this purpose. RESULTS: Data on 128 women (142 pregnancies) from 30 neurologists working in 21 cities in Brazil were collected. Patients' average age at pregnancy was 29.8 years (range 16-42). EDSS at start of pregnancy was 1.5±1.4; and the relapse rate in the year preceding pregnancy was 1.2±1.5. Exposure to medication at any time during pregnancy was high (69.7%): 48.6% to interferon beta; 14.1% to glatiramer acetate; and 7% to other immunomodulatory and immunosuppressive drugs. There was a significant decrease in relapse rate during pregnancy. The prevalence of complications was relatively low, with 4.9% of obstetric and 1.4% neonatal unfavorable outcomes. CONCLUSIONS: Our patients had low degrees of disability, short histories of disease, high drug exposure, and relatively high relapse rate in the year previous to pregnancy. Obstetric and neonatal outcomes were successful in over 90% of our patients.


Subject(s)
Multiple Sclerosis/epidemiology , Pregnancy Complications/epidemiology , Adolescent , Adult , Birth Weight/drug effects , Brazil/epidemiology , Data Interpretation, Statistical , Databases, Factual , Female , Glatiramer Acetate , Humans , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Infant, Newborn , Infant, Newborn, Diseases/epidemiology , Interferon Type I/adverse effects , Interferon Type I/therapeutic use , Multiple Sclerosis/drug therapy , Peptides/adverse effects , Peptides/therapeutic use , Pregnancy , Pregnancy Outcome , Recombinant Proteins , Recurrence , Retrospective Studies , Young Adult
4.
Arq Neuropsiquiatr ; 41(3): 292-308, 1983 Sep.
Article in Portuguese | MEDLINE | ID: mdl-6651578

ABSTRACT

A case of 38 year old man who worked with organochlorinated and Parathion during 5 years is reported. His follow-up was up to 2 years. The onset of the disease was characterized by cholinergic signs, headache, loss of weight, trembling, miokimias, fasciculations, ataxia, myotonic phenomena (in hands only) and motor sensitive peripheral polyneuropathy (affecting the lower limbs symmetrically). Low concentrations of blood cholinesterases confirmed the etiology. Myotonic phenomena disappeared spontaneously 6 months after the initial observation. One year later, the concentration of erythrocyte acetylcholinesterase was found to be low and plasma cholinesterase was normal, suggesting that the patient was carrier of a congenital deficiency of acetylcholinesterase. In literature relationship between myotonia and intoxication due to organophosphorus was not found. The whole clinical picture, cholinergic symptoms, transitory phenomena and spontaneous motor activity could be explained by an excess of acetylcholine. Electromyography (EMG) in the first observation showed neuromuscular transmission blocking characterized by deficiency or absence of voluntary activity, unexcitability of fibular nerves, with fibrillations and positive peaks as described previously with Mipafox (another organophosphorus agent). During 2 years of observation numerous end-plates potentials of muscular fibres persisted in the EMG. A progressive increase in voluntary activity showed by unit motor potential of almost normal amplitude and very increased duration was observed. No potentials of reinnervation were noted. The results of EMG were explained as disturbances of neuromuscular transmission associated with moderate signs of denervation. The Eaton-Lambert's test and the stimulation of a single unit motor potential confirmed disorder of neuromuscular synapses. The histochemistry of brachial biceps showed scattered atrophic and angulated type I and II fibres. Teased-fibres preparations showed nerve fibres with B, C, and G alterations as defined by Dyck et al. indicating axonal degeneration. These results were according to velocity of sensitive conduction. The conduction velocity of fibular nerves was strongly delayed during all the evolution indicating serious disorders of motor nerves myelin.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Cholinesterases/blood , Neuromuscular Diseases/chemically induced , Parathion/poisoning , Acetylcholine/blood , Adult , Electromyography , Humans , Male , Muscles/pathology , Neural Conduction , Sural Nerve/pathology
5.
Arq. neuropsiquiatr ; 41(3): 292-308, 1983.
Article in Portuguese | LILACS | ID: lil-14066

ABSTRACT

Estudamos um paciente com quadro clinico rebelde, produzido por intoxicacao pelo parathion. Foi observado um fenomeno miotonico transitorio, nao descrito na literatura revisada. A constatacao de cifras de AchE eritrocitaria baixas e de colinesterase plasmatica normais, indicou que era portador de deficit congenito de AchE, esclarecendo-se a evolucao cronica do seu quadro. O fenomeno miotonico associado ao quadro clinico, eletrofisiologico, histologico e bioquimico fazem deste paciente um modelo clinico, de etiologia conhecida, da discutida sindrome de Isaacs


Subject(s)
Adult , Humans , Male , Cholinesterases , Neuromuscular Diseases , Parathion
SELECTION OF CITATIONS
SEARCH DETAIL
...